当前位置:首页 >英文主页 >中英对照 > 中译版报告详情

世邦魏理仕:2026年美国生命科学地产趋势研究报告(中译版)(25页).pdf

上传人: 1****1 编号:1155645 2026-03-13 25页 3.46MB

下载:

1、2026 U.S.Life Sciences TrendsForces Driving a RecoveryCBRE RESEARCHMARCH 2026Intelligent InvestmentREPORT 2CBRE RESEARCH 2026 CBRE,INC.Intelligent Investment 2026 U.S.Life Sciences TrendsForces Driving a Recovery in 2026 1Construction will drop to decade-low levels amid stable demand Lab/R&D constru

2、ction activity will decline by 87%between Q4 2025 and Q4 2026,nearly emptying the future supply pipeline,balancing supply and demand and improving market conditions.2Capital markets signal upside for lab/R&D demandLife sciences equity market indicators and venture capital(VC)funding significantly in

3、creased heading into 2026 and are expected to boost demand for lab/R&D space.3Life sciences real estate investment activity to grow in 2026Policy uncertainty lessened and capital market conditions improved in H2 2025,reigniting life sciences real estate investment.In 2026,sales activity is expected

4、to double in four of the top U.S.markets.4Historically high facility investments will boost domestic life sciences presenceLife sciences companies are making historically high facility investments to accommodate growth amid surging domestic pharmaceutical and medicine manufacturing.5Industry megatre

5、nds will influence real estate demand and activityA historically high patent cliff,the rapid pace of scientific progress and Chinas emergence as a global life sciences force will impact U.S.lab/R&D real estate in various and different ways.4CBRE RESEARCH 2026 CBRE,INC.Intelligent Investment 2026 U.S

6、.Life Sciences Trends0510152025303540Q4 2016Q4 2017Q4 2018Q4 2019Q4 2020Q4 2021Q4 2022Q4 2023Q4 2024Q4 2025Q4 2026MSFPrimary 10 MarketsTop 3 Markets(BOS,SF,SD)CAPITAL MARKETSLife Sciences Lab/R&D Space Under ConstructionConstruction activity will fall further in 2026 4CBRE RESEARCH 2025 CBRE,INC.Sou

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **建设锐减**:2026年实验室/R&D建设活动将较2025年Q4下降87%,供应管道近乎清空,供需平衡改善。 2. **资本市场回暖**:生命科学股权市场指标及VC funding显著增长,预计推动需求;XBI指数2025年4月至2026年1月上涨84%。 3. **投资活跃**:2026年四大顶级市场地产销售量预计翻倍,实验室/R&D物业占销售额65%。 4. **制造业扩张**:美国医药制造业2025年12月产量达2009年以来最高,企业资本支出创历史纪录。 5. **需求稳定**:2025年租户需求稳定在1160万平方英尺,净吸收率连续两季度正增长,空置率自2022年来首次下降。
**市场复苏信号?** **投资机会在哪?** **专利 cliff 影响?**
客服
商务合作
小程序
服务号
折叠